
Ep112: Bernat Olle on Microbiome Therapeutics
The Long Run with Luke Timmerman
00:00
How Much Bacteria Is Enough?
Last fall you presented some what looked to be pretty encourage in phase two data in c dif a infections f. Can you talk a little bit about your lead candidate, because i know last fall you a presented some what looks to be pretty encouraging in phase twodata in c d if a infectionsf. Could you say a littlebit about what's in that product and whats what are its properties? And the in the trial. This is the fine construction of a different species of bacteria that are commentas a cin leavin the human intestion. Then we selecte bason, the ability too close trederls difficile, which is the pathagon they we're trying
Transcript
Play full episode